Petra Vinklerova
Brno, JM, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer.
Journal: Gynecologic oncology
Published: December 04, 2023
Molecular testing of endometrial carcinoma in real-world clinical practice.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: June 23, 2023
External validation study of endometrial cancer preoperative risk stratification model (ENDORISK).
Journal: Frontiers in oncology
Published: May 08, 2022
Does an Endometrial Cancer Diagnosis among Asymptomatic Patients Improve Prognosis?
Journal: Cancers
Published: December 07, 2021
Tumor Characteristic Variations between Symptomatic and Asymptomatic Endometrial Cancer.
Journal: Healthcare (Basel, Switzerland)
Published: May 20, 2021
The Clinical Significance of DJ1 and L1CAM Serum Level Monitoring in Patients with Endometrial Cancer.
Journal: Journal of clinical medicine
Published: May 02, 2021
Is the finding of endometrial hyperplasia or corporal polyp an mandatory indication for biopsy?
Journal: Ceska gynekologie
Published: June 13, 2020
A Novel Approach to Preoperative Risk Stratification in Endometrial Cancer: The Added Value of Immunohistochemical Markers.
Journal: Frontiers in oncology
Published: December 07, 2018
The role of hormonal therapy in patients with uterine carcinoma.
Journal: Ceska gynekologie
Published: November 17, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026